Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,053.00    21.50 (2.08%)
Bid:
1,048.50
Ask:
1,049.00
Spread: 0.50 (0.048%)
Market Cap: £3.38b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

2 Jul 2015 07:00

RNS Number : 9205R
Persimmon PLC
02 July 2015
 

 

TRADING UPDATE

 

THURSDAY 2 JULY 2015

 

Persimmon plc announces the following update ahead of its Half Year Results to 30 June 2015, which will be released on Tuesday 18 August 2015.

 

The Group has traded well through the first half of 2015. Customer sentiment remained resilient through the period running up to the General Election on 7 May and confidence has improved subsequently. New home legal completion volumes increased by 7% to 6,855 units (2014: 6,408) and total revenues increased by 12% to £1.34 bn (2014: £1.20 bn). Visitor numbers to our sites across the UK have been in line with the prior year and cancellation rates have remained at low levels.

 

Customer demand has been supported by an increasingly competitive mortgage market over the last six months, together with continued growth in employment and some welcome improvement in disposable incomes. The opportunity to buy a newly built home remains compelling. The average selling price for the Group increased by 4% to c. £195,000 (2014: £186,970).

 

For the first half of the year the Group's weekly rate of sale into the private sale market was 11% ahead of the prior year. At 30 June forward sales volumes into the private sale market were 12% ahead of last year at 4,606 new homes with an average selling price of c. £213,000, 4% ahead of last year. Total forward sales value at 30 June increased by 15% to £1.36 bn (2014: £1.18 bn).

 

We successfully opened 122 new sites in the first half of the year despite experiencing a slow-down in the planning application process in the period running up to the General Election. As a result our outlet network at 30 June of 395 active sites was c. 5% stronger than at the start of the year. We continue to actively develop all sites where we have an implementable detailed planning consent and plan to open a further c.125 new sites during the second half of the year.

 

The land market continues to provide attractive opportunities for investment to support the future growth of the business. We have acquired c. 11,500 new plots of land across the UK during the first half and our consented land bank at 30 June totalled c. 92,400 plots. We continue to take advantage of profitable opportunities to strengthen the land platform for the future development of the business.

 

The third payment of our Capital Return Plan of £291 million, or 95p per share, was accelerated and paid on 2 April 2015 in line with the long term strategic plan adopted by management. The Group's total free net cash inflow before capital return in the first half of the year was c. £191 million (2014: £122 million). Due to this strong liquidity cash holdings at 30 June were c. £278 million ( 30 June 2014: £326 million).

 

We will announce our Half Year Results on Tuesday 18 August 2015 and will provide further details at that time.

 

Please Note

There will be a call for analysts at 0900 BST today. Please use the dial-in details below:

 

Telephone number: +44 (0) 20 3003 2666

Conference code: Persimmon

An audiocast of the call will be available on www.corporate.persimmonhomes.com from this afternoon.

 

For further information, please contact:

 

Persimmon plc

Citigate Dewe Rogerson

Jeff Fairburn, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Tel: +44 (0)1904 642199

Tel: +44 (0)20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGNVMVGKZM
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.